Search for Clinical Trial Results

Sponsored By

Encephalitis, Japanese - 25 Studies Found

Status Study
Completed Study Name: Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Date: 2005-11-03
Interventions: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
Completed Study Name: Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
Condition: Encephalitis, Japanese B
Date: 2011-08-02
Interventions: Biological: JEVAC Each subject will receive 3 doses of JEVAC subcutaneously on Day 0, 1-4 weeks and a bo
Completed Study Name: Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Date: 2006-12-14
Interventions: Biological: Live attenuated SA 14-14-2 vaccine Live attenuated SA 14-14-2 vaccine coadministered with li
Completed Study Name: Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
Condition: Encephalitis, Japanese
Date: 2015-07-15
Interventions: Biological: SA-14-14-2 live, attenuated JE vaccine 0.5 ml (single dose), Subcutaneous
Completed Study Name: Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Date: 2013-05-05
Interventions: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
Completed Study Name: Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Condition: Japanese Encephalitis
Date: 2011-06-30
Interventions:
  • Biological: Mouse brain derived japanese encephalitis vaccine (MB-JEV)

Completed Study Name: Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
Condition: Japanese Encephalitis
Date: 2015-07-05
Interventions: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) 0.5 mL, Subcutan
Completed Study Name: A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Condition:
  • Japanese Encephalitis
  • Japanese Encephalit
    Date: 2012-07-27
    Interventions: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2 Live attenuated Japanese encephaliti
Completed Study Name: Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Date: 2005-09-20
Interventions: Drug: Ribavirin
Completed Study Name: Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country
Condition: Japanese Encephalitis
Date: 2010-12-28
Interventions:
  • Biological: IXIARO 0.25 ml i.m
Next >>>